Biotechnology Week in Review: June 17-23, 2024
Breakthrough in Gene Editing Technology Dominates Headlines This week in biotechnology saw significant advancements across multiple fronts, with gene editing […]
General Biotechnology
Resources
Tailoring Drug Delivery with Innovative Excipient Technologies
In the world of pharmaceuticals, active pharmaceutical ingredients (APIs) often take center stage. However, the unsung heroes that enable these drugs to reach their full potential are excipients – the inactive substances that play a crucial role in dru…
Tailoring Drug Delivery with Innovative Excipient Technologies Read Post »
Featured, Insights
Introducing DrugChatter: Revolutionizing Information Access
DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the power of advanced natural language processing, DrugChatter provides concise, accurate, and contextually …
Introducing DrugChatter: Revolutionizing Information Access Read Post »
General Biotechnology
The Role of Biotechnology in Developing New Vaccines
How Biotech is Revolutionizing Vaccine Development Biotechnology has emerged as a game-changing force in the field of vaccine development, enabling
The Role of Biotechnology in Developing New Vaccines Read Post »
The Intersection of Biotechnology and Business: Opportunities and Challenges
Biotechnology uses biological processes, organisms, or systems to create products and technologies that make human life better and improve the health of our planet. It is important in many areas such …
The Intersection of Biotechnology and Business: Opportunities and Challenges Read Post »
Uncategorized
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry
Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity trends in the pharmaceutical industry. The report, titled “USPTO Drug Patent and Exclusivity Study Report,” …
Tentative Approval
New tentative approval for Alembic drug dabigatran etexilate mesylate
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug pat…
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Patent Added
New patent for Gilead Sciences drug VEKLURY
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. The generic ingredient in VEKLURY is remdesivir…
Infographic
Which pharmaceutical companies have the most suspension dosed drugs?
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs are: TARO HIKMA HARROW EYE NOVITIUM PHARMA AMNEAL BAU…
Which pharmaceutical companies have the most suspension dosed drugs? Read Post »
Insights
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents
The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing data on approved drugs. This pathway allows modifications and improvements to be made to existing drugs, while pot…
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents Read Post »
